Chicago startup targets misapplied 340b drug discounts
The 340b program, under which hospitals qualify for significant discounts on drug prices if they provide sufficient public aid to the indigent, has been a growing sore point for the pharma industry, mostly because what started out as a small, focused program has ballooned into a large one, with billions of dollars of pharma sales involved.
